Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study




Jaakkola, Elina; Koponen, Marjaana; Kaasinen, Valtteri; Hietala, Jarmo; Hartikainen, Sirpa; Tolppanen, Anna‐Maija

PublisherWiley

2025

 Movement Disorders

mds.70135

0885-3185

1531-8257

DOIhttps://doi.org/10.1002/mds.70135

https://doi.org/10.1002/mds.70135

https://research.utu.fi/converis/portal/detail/Publication/505676666



Background

Previous studies suggest an association between bipolar disorder (BD) and an increased risk of Parkinson's disease (PD), but the long-term temporal relationship remains unclear. Particularly, it is unclear whether the risk of PD is influenced by the duration since BD diagnosis.

Objective

The aim was to examine the association between BD and PD across time windows extending up to 35 years before PD diagnosis.

Methods

This nationwide, register-based, nested case–control study from Finland included 22,189 incident PD patients diagnosed between 1996 and 2015 and 148,009 age-, sex-, and region-matched controls. BD diagnoses from 1972 up to the PD diagnosis date (index date) were identified from health-care registers. Conditional logistic regression was used to estimate the association between BD and PD in various exposure windows with a 0- to 35-year lag. Main analyses considered BD diagnosed at least 8 years before the index date (8-year lag).

Results

BD was diagnosed before the index date in 172 (0.87%) PD patients and 509 (0.34%) controls. Elevated PD risk was evident already with a 20-year lag between BD and PD diagnoses, with a trend toward increased risk even at 30 years. In the main analysis using the 8-year lag, BD diagnosis was associated with over a twofold higher relative risk of PD (adjusted odds ratio, 95% confidence interval: 2.32, 1.85–2.91).

Conclusions

BD is associated with a significantly elevated risk of PD, observable decades before PD onset. These findings suggest that BD may reflect a long-term vulnerability to PD rather than a short-term prodromal state, emphasizing the need to explore shared pathophysiological mechanisms. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.


E.J. reports research grants from the Finnish Medical Foundation and the Finnish Parkinson Foundation outside of the submitted work. V.K. reports research grants paid through the institution of employment from the Päivikki and Sakari Sohlberg Foundation, the Finnish Parkinson Foundation, the Finnish Cultural Foundation, and Turku University Hospital (VTR-funds); advisory board fees (AbbVie, Nordic Infucare, and Merz); speaker honoraria (AbbVie, Nordic Infucare, Bial, Lundbeck, Orion, Teva, and Eisai); and travel expenses (Nordic Infucare), all outside of the submitted work. A.-M.T. reports research grants from the European Commission Horizon program, participation in the European Medicines Agency framework contracts, The Michael J. Fox Foundation for Parkinson's Research, and Sanofi, paid through the institution of employment, outside of the submitted work.
Open access publishing facilitated by Ita-Suomen yliopisto, as part of the Wiley - FinELib agreement.


Last updated on 12/01/2026 04:23:42 PM